Expert guidelines help to make it easier to identify and treat patients with hereditary hair loss
The active ingredient in REGAINE® recognised as the only over-the-counter treatment proven to work by European Dermatology Forum.
An international expert consensus has been reached on the effective identification and treatment of hereditary hair loss, providing invaluable guidance to pharmacists.
The European Dermatology Forum conducted its first evidence-based analysis of all therapeutic options for hereditary hair loss and agreed a set of recommendations to improve patient treatment for a condition that can significantly reduce quality of life.
The new guidelines recommend just one over-the-counter treatment option for men and women - minoxidil - the active ingredient in REGAINE®. It was chosen because of its safety profile and strong supporting evidence that it prevents the progression of hair loss and improves hair growth.
Minoxidil works by increasing blood supply to hair follicles, increasing hair shaft diameter and prolonging the hair growth phase for a thicker, fuller head of hair.
Categories: Regaine
.gif)
